These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18940613)

  • 1. A potent peptidomimetic inhibitor of botulinum neurotoxin serotype A has a very different conformation than SNAP-25 substrate.
    Zuniga JE; Schmidt JJ; Fenn T; Burnett JC; Araç D; Gussio R; Stafford RG; Badie SS; Bavari S; Brunger AT
    Structure; 2008 Oct; 16(10):1588-97. PubMed ID: 18940613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate binding mode and its implication on drug design for botulinum neurotoxin A.
    Kumaran D; Rawat R; Ahmed SA; Swaminathan S
    PLoS Pathog; 2008 Sep; 4(9):e1000165. PubMed ID: 18818739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SNAP-25 substrate peptide (residues 180-183) binds to but bypasses cleavage by catalytically active Clostridium botulinum neurotoxin E.
    Agarwal R; Swaminathan S
    J Biol Chem; 2008 Sep; 283(38):25944-51. PubMed ID: 18658150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of a potent cyclic peptide inhibitor with the light chain of botulinum neurotoxin A: Insights from X-ray crystallography.
    Kumaran D; Adler M; Levit M; Krebs M; Sweeney R; Swaminathan S
    Bioorg Med Chem; 2015 Nov; 23(22):7264-73. PubMed ID: 26522088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique substrate recognition by botulinum neurotoxins serotypes A and E.
    Chen S; Barbieri JT
    J Biol Chem; 2006 Apr; 281(16):10906-11. PubMed ID: 16478727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of substrate recognition by botulinum neurotoxin serotype A.
    Chen S; Kim JP; Barbieri JT
    J Biol Chem; 2007 Mar; 282(13):9621-9627. PubMed ID: 17244603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing BoNT/A protease exosites: implications for inhibitor design and light chain longevity.
    Xue S; Javor S; Hixon MS; Janda KD
    Biochemistry; 2014 Nov; 53(43):6820-4. PubMed ID: 25295706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type A botulinum neurotoxin proteolytic activity: development of competitive inhibitors and implications for substrate specificity at the S1' binding subsite.
    Schmidt JJ; Stafford RG; Bostian KA
    FEBS Lett; 1998 Sep; 435(1):61-4. PubMed ID: 9755859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple pocket recognition of SNAP25 by botulinum neurotoxin serotype E.
    Chen S; Barbieri JT
    J Biol Chem; 2007 Aug; 282(35):25540-7. PubMed ID: 17609207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycine insertion at protease cleavage site of SNAP25 resists cleavage but enhances affinity for botulinum neurotoxin serotype A.
    Ho M; Goh CH; Brothers MC; Wang S; Young RL; Ou Y; Lui JN; Kalafatis M; Lan X; Wolf AE; Rienstra CM; Wilson BA
    Protein Sci; 2012 Mar; 21(3):318-26. PubMed ID: 22170566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iterative structure-based peptide-like inhibitor design against the botulinum neurotoxin serotype A.
    Zuniga JE; Hammill JT; Drory O; Nuss JE; Burnett JC; Gussio R; Wipf P; Bavari S; Brunger AT
    PLoS One; 2010 Jun; 5(6):e11378. PubMed ID: 20614028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.
    Arndt JW; Chai Q; Christian T; Stevens RC
    Biochemistry; 2006 Mar; 45(10):3255-62. PubMed ID: 16519520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and biochemical studies of botulinum neurotoxin serotype C1 light chain protease: implications for dual substrate specificity.
    Jin R; Sikorra S; Stegmann CM; Pich A; Binz T; Brunger AT
    Biochemistry; 2007 Sep; 46(37):10685-93. PubMed ID: 17718519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational sampling of the botulinum neurotoxin serotype A light chain: implications for inhibitor binding.
    Burnett JC; Schmidt JJ; McGrath CF; Nguyen TL; Hermone AR; Panchal RG; Vennerstrom JL; Kodukula K; Zaharevitz DW; Gussio R; Bavari S
    Bioorg Med Chem; 2005 Jan; 13(2):333-41. PubMed ID: 15598556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C terminus of the catalytic domain of type A botulinum neurotoxin may facilitate product release from the active site.
    Mizanur RM; Frasca V; Swaminathan S; Bavari S; Webb R; Smith LA; Ahmed SA
    J Biol Chem; 2013 Aug; 288(33):24223-33. PubMed ID: 23779108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the catalytic properties of the botulinum neurotoxin subtypes A1 and A5.
    Wang D; Krilich J; Pellett S; Baudys J; Tepp WH; Barr JR; Johnson EA; Kalb SR
    Biochim Biophys Acta; 2013 Dec; 1834(12):2722-8. PubMed ID: 24096023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage.
    Vaidyanathan VV; Yoshino K; Jahnz M; Dörries C; Bade S; Nauenburg S; Niemann H; Binz T
    J Neurochem; 1999 Jan; 72(1):327-37. PubMed ID: 9886085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocrystal structure of synaptobrevin-II bound to botulinum neurotoxin type B at 2.0 A resolution.
    Hanson MA; Stevens RC
    Nat Struct Biol; 2000 Aug; 7(8):687-92. PubMed ID: 10932255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential endopeptidase activity of different forms of type A botulinum neurotoxin: A unique relationship between the size of the substrate and activity of the enzyme.
    Ambrin G; Kumar R; Singh BR
    Toxicon; 2018 Mar; 144():34-41. PubMed ID: 29309744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum neurotoxin A and neurotoxin E cleavage products of synaptosome-associated protein of 25 kd exhibit distinct actions on pancreatic islet beta-cell Kv2.1 channel gating.
    He Y; Elias CL; Huang YC; Gao X; Leung YM; Kang Y; Xie H; Chaddock JA; Tsushima RG; Gaisano HY
    Pancreas; 2008 Jan; 36(1):10-7. PubMed ID: 18192874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.